A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of allogeneic and autologous hematopoietic cellular therapy (HCT), associated with significant morbidity and mortality. Although the central drivers of the disease are thought to be endothelial damag...
Main Authors: | Michelle L. Schoettler, Harshil Bhatt, Sumithira Vasu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1064203/full |
Similar Items
-
Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option
by: Elena Román, et al.
Published: (2017-09-01) -
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
by: Eleni Gavriilaki, et al.
Published: (2022-06-01) -
Pregnancy as a susceptible state for thrombotic microangiopathies
by: Marie Frimat, et al.
Published: (2024-02-01) -
Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
by: Miquel Blasco, et al.
Published: (2022-04-01) -
Transplant-associated thrombotic microangiopathy
by: Tomasz Jarmoliński
Published: (2021-09-01)